Peter Laimons Naruns, MD
Surgery · Mountain View
- Medicare standing
- 1 flag on the record
- Listed below.
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
On the public record
- Medicare does not list them as allowed to order and refer
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Naruns’s office at (650) 964-0600 to ask if they take your plan before you enroll.
California Medical Board record
Licence G50961 · Current
Licensed to practise in California · since 1983 · expires 2027-03-31 · Temple University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Drugs they prescribed that Part D paid
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 57% of their 28 Part D prescriptions in 2021. Too few prescriptions to judge: with under about 50 a year, a handful of patients can swing this share.
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
Year by year
| 2021 | 28 | 20 | 57% (16) | None | $375 |
| 2020 | 15 | 13 | None | None | $115 |
| 2019 | 32 | 21 | 56% (18) | None | $259 |
| 2018 | 31 | 29 | 77% (24) | 0% | $184 |
| 2017 | 55 | 40 | 69% (38) | None | $351 |
| 2016 | 40 | 32 | 78% (31) | 0% | $319 |
| 2015 | 29 | 23 | 72% (21) | None | $386 |
| 2014 | 41 | 32 | 61% (25) | 0% | $439 |
| 2013 | 31 | 27 | 84% (26) | None | $313 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2021: 1 drug
| Hydrocodone-Acetaminophen | 16 | $129 | $8 |
2019: 1 drug
| Hydrocodone-Acetaminophen | 17 | $92 | $5 |
2018: 1 drug
| Hydrocodone-Acetaminophen | 23 | $137 | $6 |
2017: 1 drug
| Hydrocodone-Acetaminophen | 36 | $200 | $6 |
2016: 1 drug
| Hydrocodone-Acetaminophen | 30 | $223 | $7 |
2015: 1 drug
| Hydrocodone-Acetaminophen | 20 | $128 | $6 |
2014: 1 drug
| Hydrocodone-Acetaminophen | 20 | $158 | $8 |
2013: 1 drug
| Hydrocodone-Acetaminophen | 26 | $198 | $8 |
Money from drug and device companies
$190 in 2020
| 2020 | 9 | 9 | None | $190 |
| 2019 | 15 | 35 | None | $735 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Seagen | Adcetris | $30 | 1 payment
|
| Blueprint Medicines | Ayvakit | $25 | 1 payment
|
| Incyte | Jakafi | $23 | 1 payment
|
| Amarin Pharma | Vascepa | $23 | 1 payment
|
| Novartis Pharmaceuticals | Tasigna | $20 | 1 payment
|
| Novo Nordisk | Ozempic | $20 | 1 payment
|
See all 9 published payments
| Blueprint Medicines | Meals · 2020-03-16 | Ayvakit | $25 |
| Novo Nordisk | Meals · 2020-03-11 | Ozempic | $20 |
| Incyte | Meals · 2020-03-10 | Jakafi | $23 |
| Seagen | Meals · 2020-03-04 | Adcetris | $30 |
| Amarin Pharma | Meals · 2020-02-26 | Vascepa | $23 |
| Janssen Biotech | Meals · 2020-02-05 | Darzalex | $18 |
| Foundation Medicine | Meals · 2020-01-28 | Foundationone | $16 |
| Novartis Pharmaceuticals | Meals · 2020-01-27 | Tasigna | $20 |
| AstraZeneca Pharmaceuticals LP | Meals · 2020-01-15 | Imfinzi | $15 |
See earlier years (2019)
2019: $735
| Novartis Pharmaceuticals | Votrient | $157 | 8 payments
|
| Takeda Pharmaceuticals U.S.A. | None | $112 | 4 payments
|
| Amgen | Evenity | $84 | 3 payments
|
| E.R. Squibb & Sons L.L.C. | Empliciti | $69 | 4 payments
|
| Bayer HealthCare Pharmaceuticals | Nubeqa | $57 | 3 payments
|
| Incyte | Jakafi | $52 | 3 payments
|
| Intuitive Surgical | Da Vinci Surgical System | $39 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Imfinzi | $34 | 2 payments
|
| Janssen Biotech | Darzalex | $24 | 1 payment
|
| Myriad Genetic Laboratories | Bracanalysis Cdx | $23 | 1 payment
|
| Tesaro | Zejula | $19 | 1 payment
|
| Davol | Bd Max | $19 | 1 payment
|
| Celgene | Revlimid | $16 | 1 payment
|
| Eisai | Halaven | $16 | 1 payment
|
| Foundation Medicine | Foundationone | $13 | 1 payment
|
Professional record
- NPI
- 1689636680
- Licence
- CA G50961California G50961: Current · expires 2027-03-31
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00G509610
- Taxonomy
- Surgery (208600000X); Surgical oncology (2086X0206X)
- Mailing address
- 2204 Grant Road, Suite 203, Mountain View, CA, 94040
- NPI first listed
- 2006-04-05
- NPI last updated
- 2011-10-07
This is when the NPI record was last certified, not a medical board exam.